Boston Scientific has initiated a Class II recall of its StoneSmart Connect Console power adapters, affecting 982 units distributed across the US and multiple international markets. The recall comes as the company's shares have eased 1.7% over the last trading day and are down 6.2% over the past month, with a 1-year total shareholder return down 54.7%. Boston Scientific closed at $43.92, well below a widely followed fair value narrative of $61.07 that implies 28% undervaluation. The company is pursuing a restructuring program targeting about US$500m in annual run rate savings exiting 2029, alongside a US$2b share repurchase completed in Q2 2026, even as near-term guidance reflects WATCHMAN, EP and cyberattack related pressure. The bull case could crack if Electrophysiology and WATCHMAN weakness lingers longer than analysts assume or if the Penumbra deal proves harder to integrate.
Boston Scientific CorpBoston Scientific initiated a Class II recall of 982 StoneSmart Connect Console power adapters across US and international markets.
Penumbra Inc